Suppr超能文献

从肽-蛋白酶融合体的反向翻转文库中筛选具有增加结合熵的高亲和力肽类丝氨酸蛋白酶抑制剂。

Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide-Protease Fusions.

作者信息

Sørensen Hans Peter, Xu Peng, Jiang Longguang, Kromann-Hansen Tobias, Jensen Knud J, Huang Mingdong, Andreasen Peter A

机构信息

Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark.

Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, 350002 Fuzhou, People's Republic of China.

出版信息

J Mol Biol. 2015 Sep 25;427(19):3110-22. doi: 10.1016/j.jmb.2015.08.005. Epub 2015 Aug 14.

Abstract

We have developed a new concept for designing peptidic protein modulators, by recombinantly fusing the peptidic modulator, with randomized residues, directly to the target protein via a linker and screening for internal modulation of the activity of the protein. We tested the feasibility of the concept by fusing a 10-residue-long, disulfide-bond-constrained inhibitory peptide, randomized in selected positions, to the catalytic domain of the serine protease murine urokinase-type plasminogen activator. High-affinity inhibitory peptide variants were identified as those that conferred to the fusion protease the lowest activity for substrate hydrolysis. The usefulness of the strategy was demonstrated by the selection of peptidic inhibitors of murine urokinase-type plasminogen activator with a low nanomolar affinity. The high affinity could not have been predicted by rational considerations, as the high affinity was associated with a loss of polar interactions and an increased binding entropy.

摘要

我们已经开发出一种设计肽类蛋白质调节剂的新概念,即通过将带有随机化残基的肽类调节剂经连接子直接重组融合到靶蛋白上,并筛选蛋白质活性的内部调节作用。我们通过将一个10个残基长、具有二硫键约束的抑制性肽(在选定位置随机化)融合到丝氨酸蛋白酶小鼠尿激酶型纤溶酶原激活剂的催化结构域,来测试这一概念的可行性。高亲和力抑制性肽变体被鉴定为那些赋予融合蛋白酶最低底物水解活性的变体。通过选择具有低纳摩尔亲和力的小鼠尿激酶型纤溶酶原激活剂的肽类抑制剂,证明了该策略的有效性。由于高亲和力与极性相互作用的丧失和结合熵增加相关联,因此无法通过理性思考预测到这种高亲和力。

相似文献

2
A cyclic peptidic serine protease inhibitor: increasing affinity by increasing peptide flexibility.
PLoS One. 2014 Dec 29;9(12):e115872. doi: 10.1371/journal.pone.0115872. eCollection 2014.
3
The binding mechanism of a peptidic cyclic serine protease inhibitor.
J Mol Biol. 2011 Sep 16;412(2):235-50. doi: 10.1016/j.jmb.2011.07.028. Epub 2011 Jul 23.
8
Cleavage of peptidic inhibitors by target protease is caused by peptide conformational transition.
Biochim Biophys Acta Gen Subj. 2018 Sep;1862(9):2017-2023. doi: 10.1016/j.bbagen.2018.06.016. Epub 2018 Jun 27.
9
Bicyclic peptide inhibitor of urokinase-type plasminogen activator: mode of action.
Chembiochem. 2013 Nov 4;14(16):2179-88. doi: 10.1002/cbic.201300335. Epub 2013 Oct 2.

引用本文的文献

2
Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.
Int J Biol Sci. 2017 Sep 21;13(10):1222-1233. doi: 10.7150/ijbs.21597. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验